NO20075671L - Neurodegenerative markorer for psykiatriske tilstander - Google Patents

Neurodegenerative markorer for psykiatriske tilstander

Info

Publication number
NO20075671L
NO20075671L NO20075671A NO20075671A NO20075671L NO 20075671 L NO20075671 L NO 20075671L NO 20075671 A NO20075671 A NO 20075671A NO 20075671 A NO20075671 A NO 20075671A NO 20075671 L NO20075671 L NO 20075671L
Authority
NO
Norway
Prior art keywords
psychiatric conditions
markers
neurodegenerative
disease
values
Prior art date
Application number
NO20075671A
Other languages
English (en)
Norwegian (no)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Harald Hampel
Norbert Mueller
Original Assignee
Klinik Und Poliklinik Fuer Psy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinik Und Poliklinik Fuer Psy filed Critical Klinik Und Poliklinik Fuer Psy
Publication of NO20075671L publication Critical patent/NO20075671L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
NO20075671A 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander NO20075671L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
NO20075671L true NO20075671L (no) 2007-11-06

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20075671A NO20075671L (no) 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Country Status (14)

Country Link
US (2) US20080131921A1 (ja)
EP (2) EP1866650B1 (ja)
JP (1) JP4958893B2 (ja)
AT (2) ATE534038T1 (ja)
CY (1) CY1110116T1 (ja)
DE (1) DE602006014379D1 (ja)
DK (2) DK2146209T3 (ja)
ES (2) ES2377704T3 (ja)
HK (1) HK1137219A1 (ja)
NO (2) NO20075671L (ja)
PL (2) PL1866650T3 (ja)
PT (2) PT1866650E (ja)
SI (1) SI1866650T1 (ja)
WO (1) WO2006105907A1 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
KR20180001596A (ko) 2008-01-18 2018-01-04 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
DK2466312T3 (da) 2009-08-12 2020-01-13 Human Metabolome Tech Inc Phosphoethanolamine som biomarkør for depression
EP4303584A3 (en) 2010-07-23 2024-04-03 President and Fellows of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
WO2012012694A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
WO2013069645A1 (ja) 2011-11-10 2013-05-16 ヒューマン・メタボローム・テクノロジーズ株式会社 エタノールアミンリン酸の測定方法
MX2014015425A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones.
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
WO2017185085A1 (en) * 2016-04-22 2017-10-26 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
WO2019067660A1 (en) * 2017-09-27 2019-04-04 University of North Carolina Wilmington TOOL FOR DETECTION OF PATHOGENIC AGENTS DERIVED FROM MAN AND HUMAN WASTEWATER
CN111886501A (zh) * 2018-03-19 2020-11-03 富士胶片和光纯药株式会社 精神疾病的判断方法
CA3094504A1 (en) * 2018-03-22 2019-09-26 Japan Medical Device Technology Co., Ltd. Bioabsorbable stent
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
JP7389139B2 (ja) * 2019-11-26 2023-11-29 京セラ株式会社 ストレス計測システムおよびストレス計測方法
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
PT2146209E (pt) 2011-12-30
ES2377704T3 (es) 2012-03-30
JP4958893B2 (ja) 2012-06-20
PL1866650T3 (pl) 2011-04-29
EP2146209A1 (en) 2010-01-20
NO20120452L (no) 2007-11-06
PL2146209T3 (pl) 2012-05-31
JP2008537111A (ja) 2008-09-11
ATE534038T1 (de) 2011-12-15
HK1137219A1 (en) 2010-07-23
PT1866650E (pt) 2010-06-01
EP1866650A1 (en) 2007-12-19
WO2006105907A1 (en) 2006-10-12
DK1866650T3 (da) 2010-09-06
SI1866650T1 (sl) 2010-12-31
EP1866650B1 (en) 2010-05-19
US20120196300A1 (en) 2012-08-02
DK2146209T3 (da) 2012-02-13
US20080131921A1 (en) 2008-06-05
CY1110116T1 (el) 2015-01-14
ATE468537T1 (de) 2010-06-15
EP2146209B1 (en) 2011-11-16
ES2346467T3 (es) 2010-10-15
DE602006014379D1 (de) 2010-07-01

Similar Documents

Publication Publication Date Title
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
WO2005047484A3 (en) Biomarkers for alzheimer's disease
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
DE60100053D1 (de) Sensor zur Messung des Spiels mittels mehrstufigen Abriebs
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
DE602004006664D1 (de) Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors
DK1330656T3 (da) Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DK1747465T3 (da) Anvendelse af hidtil ukendte biomarkører til detektion af testikelcarcinom in situ og afledte cancere i humane prøver
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
NO20030216L (no) Fremgangsmåte for å detektere patogene prionproteiner ved hjelp av massespektroskopi
DK1558929T3 (da) Kvantificering af stresseksponering
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
ATE442084T1 (de) Messung des energieverbrauchs
ATE511643T1 (de) Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer
UA11937S (uk) Кашкет чоловічий формений
UA11938S (uk) Кашкет чоловічий формений

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application